-
Something wrong with this record ?
Regional geographic variations in kidney cancer incidence rates in European countries
P. Li, A. Znaor, I. Holcatova, E. Fabianova, D. Mates, MB. Wozniak, J. Ferlay, G. Scelo,
Language English Country Switzerland
Document type Journal Article, Review
- MeSH
- Time Factors MeSH
- Incidence MeSH
- Humans MeSH
- Kidney Neoplasms diagnosis epidemiology etiology prevention & control MeSH
- National Health Programs statistics & numerical data trends MeSH
- Risk Factors MeSH
- Sex Factors MeSH
- Check Tag
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Review MeSH
- Geographicals
- Europe MeSH
CONTEXT: Marked unexplained national variations in incidence rates of kidney cancer have been observed for decades in Europe. OBJECTIVE: To investigate geographic variations at the regional level and identify European regions with high incidence rates of kidney cancer. EVIDENCE ACQUISITION: Regional- and national-level incidence data were extracted from the Cancer Incidence in Five Continents databases, local cancer registry databases, and local published reports. World population age-standardised rates (ASRs) were calculated for the periods 2003-2007 and 1988-1992. Rates by period and sex were compared using map visualisation. EVIDENCE SYNTHESIS: During 2003-2007, the highest ASR was found in the Plzen region, Czech Republic (31.4/100,000 person-years in men). Other regions of the Czech Republic had ASRs of 18.6-27.5/100,000 in men, with a tendency for higher rates in regions south of Prague. Surrounding regions, including eastern Germany and regions of Slovakia and Austria, had medium-to-high incidence rates (13.0-16.8/100,000 in men). Three other areas in Europe showed higher incidence rates in men compared with the rest of the continent: Lithuania, Estonia, Latvia, and Belarus (15.0-17.6/100,000); Iceland (13.5/100,000), and northern Italy (up to 16.0/100,000). Similar regional differences were observed among women, with rates approximately half of those observed in men in the same region. In general, these regional geographic variations remained stable over the periods 1988-1992 and 2003-2007, although higher incidence rates were detected in the Baltic countries in 2003-2007. CONCLUSIONS: Several European regions show particularly high rates of kidney cancer incidence. Large variations were observed within countries covered by national health-care systems, implying that overdetection is not the major factor. PATIENT SUMMARY: We present regional geographic variations in kidney cancer incidence rates in Europe. We highlight several regions with high incidence rates where further studies should be conducted for cancer control and prevention.
International Agency for Research on Cancer Lyon France
National Institute of Public Health Bucharest Romania
Regional Authority of Public Health in Banska Bystrica Banska Bystrica Slovakia
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc16021026
- 003
- CZ-PrNML
- 005
- 20160727094919.0
- 007
- ta
- 008
- 160722s2015 sz f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.eururo.2014.11.001 $2 doi
- 024 7_
- $a 10.1016/j.eururo.2014.11.001 $2 doi
- 035 __
- $a (PubMed)25465966
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sz
- 100 1_
- $a Li, Peng $u International Agency for Research on Cancer, Lyon, France.
- 245 10
- $a Regional geographic variations in kidney cancer incidence rates in European countries / $c P. Li, A. Znaor, I. Holcatova, E. Fabianova, D. Mates, MB. Wozniak, J. Ferlay, G. Scelo,
- 520 9_
- $a CONTEXT: Marked unexplained national variations in incidence rates of kidney cancer have been observed for decades in Europe. OBJECTIVE: To investigate geographic variations at the regional level and identify European regions with high incidence rates of kidney cancer. EVIDENCE ACQUISITION: Regional- and national-level incidence data were extracted from the Cancer Incidence in Five Continents databases, local cancer registry databases, and local published reports. World population age-standardised rates (ASRs) were calculated for the periods 2003-2007 and 1988-1992. Rates by period and sex were compared using map visualisation. EVIDENCE SYNTHESIS: During 2003-2007, the highest ASR was found in the Plzen region, Czech Republic (31.4/100,000 person-years in men). Other regions of the Czech Republic had ASRs of 18.6-27.5/100,000 in men, with a tendency for higher rates in regions south of Prague. Surrounding regions, including eastern Germany and regions of Slovakia and Austria, had medium-to-high incidence rates (13.0-16.8/100,000 in men). Three other areas in Europe showed higher incidence rates in men compared with the rest of the continent: Lithuania, Estonia, Latvia, and Belarus (15.0-17.6/100,000); Iceland (13.5/100,000), and northern Italy (up to 16.0/100,000). Similar regional differences were observed among women, with rates approximately half of those observed in men in the same region. In general, these regional geographic variations remained stable over the periods 1988-1992 and 2003-2007, although higher incidence rates were detected in the Baltic countries in 2003-2007. CONCLUSIONS: Several European regions show particularly high rates of kidney cancer incidence. Large variations were observed within countries covered by national health-care systems, implying that overdetection is not the major factor. PATIENT SUMMARY: We present regional geographic variations in kidney cancer incidence rates in Europe. We highlight several regions with high incidence rates where further studies should be conducted for cancer control and prevention.
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a incidence $7 D015994
- 650 _2
- $a nádory ledvin $x diagnóza $x epidemiologie $x etiologie $x prevence a kontrola $7 D007680
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a programy národního zdraví $x statistika a číselné údaje $x trendy $7 D009313
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a sexuální faktory $7 D012737
- 650 _2
- $a časové faktory $7 D013997
- 651 _2
- $a Evropa $x epidemiologie $7 D005060
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Znaor, Ariana $u International Agency for Research on Cancer, Lyon, France.
- 700 1_
- $a Holcatova, Ivana $u First Faculty of Medicine, Institute of Hygiene and Epidemiology, Charles University, Prague, Czech Republic.
- 700 1_
- $a Fabianova, Eleonora $u Regional Authority of Public Health in Banska Bystrica, Banska Bystrica, Slovakia.
- 700 1_
- $a Mates, Dana $u National Institute of Public Health, Bucharest, Romania.
- 700 1_
- $a Wozniak, Magdalena B $u International Agency for Research on Cancer, Lyon, France.
- 700 1_
- $a Ferlay, Jacques $u International Agency for Research on Cancer, Lyon, France.
- 700 1_
- $a Scelo, Ghislaine $u International Agency for Research on Cancer, Lyon, France. Electronic address: scelog@iarc.fr.
- 773 0_
- $w MED00001669 $t European urology $x 1873-7560 $g Roč. 67, č. 6 (2015), s. 1134-41
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/25465966 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20160722 $b ABA008
- 991 __
- $a 20160727095140 $b ABA008
- 999 __
- $a ok $b bmc $g 1155696 $s 945554
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2015 $b 67 $c 6 $d 1134-41 $e 20141118 $i 1873-7560 $m European urology $n Eur Urol $x MED00001669
- LZP __
- $a Pubmed-20160722
